Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Surgical and Transcatheter Approach of a Failed Mitral Valve Repair: A Comprehensive Review on Selecting the Most Suitable Approach.

Journal of clinical medicine·2026
Same author

Preliminary Outcome of Transcatheter Aortic Valve Implantation at Centers Without On-Site Cardiac Surgery.

Journal of cardiovascular development and disease·2026
Same author

When Mitral Repair Fails: Understanding Recurrence, Risk Factors, and Treatment Choices.

Journal of cardiovascular development and disease·2026
Same author

Low Arrhythmic Risk in Individuals With Brugada ECG Pattern and a Negative dST-Tiso Criterion.

The American journal of cardiology·2026
Same author

Evolving Demographics and Outcomes in Surgically Treated Acute Type A Aortic Dissection: A Fifteen-Year Regional Experience.

Medicina (Kaunas, Lithuania)·2025
Same author

Enhanced Risk Stratification in Infective Endocarditis Surgery: A Comprehensive External Validation of All Available Mortality Prediction Scores.

Clinical epidemiology·2025

相关实验视频

Updated: May 10, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.2K

优化大动脉的重置手术:小胸切除术与全胸切除术.

Elisa Mikus1, Mariafrancesca Fiorentino1, Diego Sangiorgi1

  • 1Cardiovascular Department, Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Italy.

Journal of clinical medicine
|February 26, 2025
PubMed
概括

最少侵入性大动脉重置手术在之前心脏手术的患者中与传统的胸骨切除术一样安全. 这种方法可以缩短手术时间,减少功能衰竭等并发症,降低早期死亡率.

关键词:
大动脉门重新运行微创手术是最少的侵入性手术.重新启动的运行情况.没有紧的专利内部乳腺动脉

更多相关视频

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.9K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.6K

相关实验视频

Last Updated: May 10, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.2K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.9K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.6K

科学领域:

  • 心脏外科手术 心脏外科手术
  • 最少侵入性手术的方法
  • 大动脉门的更换

背景情况:

  • 通过 ministernotomy进行最小侵入性大动脉置换 (AVR) 是常见的,但其在重新手术的情况下的疗效尚不确定.
  • 这项研究评估了先前心脏手术的患者的微创性AVR与传统的胸骨切除术.

研究的目的:

  • 为了比较最小侵入性AVR的安全性和结果与在重复手术患者中进行传统的胸腔切除术.
  • 评估两种手术方法之间的手术时间,并发症和死亡率的差异.

主要方法:

  • 对382名接受再手术AVR的患者的回顾性分析 (2010年1月 - 2024年6月).
  • 通过上部宫切除术进行的最小侵入性AVR (n=73) 与传统的全宫切除术 (n=309) 的比较.
  • 用于最小化偏差的治疗权重的逆概率 (IPTW).

主要成果:

  • 最少侵入性的AVR有显著缩短的大动脉十字和心肺旁路时间.
  • 最少侵入性组经历了更短的重症监护室停留时间,更低的急性功能衰竭率和更少的血液损失.
  • 在微创手术组中,早期死亡率明显较低 (1.6%与4.5%相比).

结论:

  • 通过上部"J"胸腔切除术进行最小侵入性大动脉重新操作是完全胸腔切除术的安全替代方案.
  • 这种方法可以改善患者的康复,并减少急性功能衰竭和术后出血.
  • 最少侵入性再手术AVR与医院死亡率降低有关.